TAGLN3

transgelin 3

Basic information

Region (hg38): 3:111998739-112013887

Links

ENSG00000144834 ∙ NCBI:29114 ∙ OMIM:607953 ∙ HGNC:29868 ∙ Uniprot:Q9UI15 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TAGLN3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAGLN3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous						0
missense			11			11
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	11	0	0

Variants in TAGLN3

This is a list of pathogenic ClinVar variants found in the TAGLN3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
3-111999547-T-G		not specified	Uncertain significance (May 30, 2023)
3-111999549-G-A		not specified	Uncertain significance (Mar 13, 2023)
3-111999559-C-T		not specified	Uncertain significance (Jun 13, 2023)
3-111999564-G-A		not specified	Uncertain significance (Feb 16, 2023)
3-112000802-C-G		not specified	Uncertain significance (Nov 18, 2022)
3-112000899-A-G		not specified	Uncertain significance (Aug 17, 2021)
3-112011775-C-A		not specified	Uncertain significance (Jun 05, 2023)
3-112011838-A-G		not specified	Uncertain significance (Jun 09, 2022)
3-112011840-C-T		not specified	Uncertain significance (Mar 07, 2024)
3-112013418-A-C		not specified	Uncertain significance (Mar 29, 2024)
3-112013467-C-G		not specified	Uncertain significance (Jan 29, 2024)
3-112013516-A-C		not specified	Uncertain significance (Sep 29, 2023)
3-112013516-A-G		not specified	Uncertain significance (Mar 29, 2024)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
TAGLN3	protein_coding	protein_coding	ENST00000393917	4	15224

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.185	0.805	125740	0	8	125748	0.0000318

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	1.57	71	119	0.596	0.00000614	1313
Missense in Polyphen		15	34.711	0.43214		418
Synonymous	0.248	45	47.2	0.954	0.00000277	360
Loss of Function	2.21	3	10.8	0.277	4.65e-7	119

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.000148	0.000148
Ashkenazi Jewish	0.00	0.00
East Asian	0.0000545	0.0000544
Finnish	0.00	0.00
European (Non-Finnish)	0.00000879	0.00000879
Middle Eastern	0.0000545	0.0000544
South Asian	0.0000654	0.0000653
Other	0.00	0.00

dbNSFP

Source: dbNSFP

Recessive Scores

• pRec: 0.130

Intolerance Scores

• loftool: 0.471
• rvis_EVS: -0.03
• rvis_percentile_EVS: 51.04

Haploinsufficiency Scores

• pHI: 0.236
• hipred: Y
• hipred_score: 0.768
• ghis: 0.655

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.363

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Low	Low
Primary Immunodeficiency	Medium	Low	Medium
Cancer	Low	Low	Low

Mouse Genome Informatics

• Gene name: Tagln3

Gene ontology

• Biological process: negative regulation of transcription by RNA polymerase II;central nervous system development
• Cellular component: nucleus;myelin sheath
• Molecular function: actin filament binding